ModelEdge
Regeneron Pharmaceuticals, Inc.
REGN
Filing type
10-Q
Filing date
Jul 29, 2026
Updated
Jul 30, 2026 ยท 4:52 AM

Filing

10-QQ2

Exhibits

EX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C SECTION 1350